Chronic subdural hematoma is a common neurosurgical condition that occurs particularly often in older adults after a fall with head impact. It is a chronic collection of blood between the brain and the dura mater.
Epidemiology
In patients over 70 years of age, chronic subdural hematoma occurs with an incidence of 58/100000 persons1.
Causes and Pathophysiology
Chronic subdural hematoma often occurs several weeks after a fall and probably develops from an initially small acute subdural hematoma2. Blood in the subdural space triggers an inflammatory response, leading to the migration of fibroblasts and the formation of neomembranes on the cortical and dural surfaces of the hematoma3. This subsequently leads to the formation of neocapillaries, enzymatic fibrinolysis, and consequent liquefaction of the blood clot4. Fibrin degradation products are redistributed into new blood clots and inhibit hemostasis. The course of a chronic subdural hematoma is determined by a balance between plasma effusion and/or recurrent bleeding from the neomembranes on the one hand and resorption of the hematoma on the other5 6.
Risk Factors
The use of medications that inhibit platelet aggregation, such as aspirin or clopidogrel, or that affect coagulation promotes the development of chronic subdural hematoma. Known risk factors for the development of chronic subdural hematoma include age, alcohol dependence, epileptic seizures, cerebrospinal fluid shunts, and cerebral atrophy7 8. A history of trauma is not always present. 29-38% of all patients have no remembered history of a fall9.
Symptoms
Symptoms of chronic subdural hematoma often develop slowly and frequently present with mild symptoms such as headache, confusion, or speech disturbances10. The symptoms may also be more pronounced and manifest as hemiparesis progressing to hemiplegia. Seizures of varying severity, including comatose states, may also occur11. The Markwalder Classification can be used for academic quantification of clinical severity; based on the clinical condition, it categorizes patients into five different grades.
Imaging
The gold standard in the imaging diagnosis of chronic subdural hematoma is CT imaging of the head. The diagnosis can also be made with MRI.
Treatment Options
In some cases, chronic subdural hematoma is diagnosed incidentally, and the patient is asymptomatic. If the hematoma is also small in such a case, conservative treatment may be an option.
Surgical Treatment
Burr-Hole Trepanation and Craniotomy
Surgical removal of a chronic subdural hematoma is one of the most common neurosurgical procedures. Typically, two burr holes are created on the affected side using a trephine, through which the chronic hematoma can be irrigated. In some cases, there are extensive septations between the fluid hematoma components, which significantly complicate the operation. The burr holes made in the calvaria are usually covered only with a titanium plate for cosmetic reasons, to prevent the skin from sinking in at this site. In rare cases, the hematoma components cannot be removed as intended through the burr holes, and the procedure must be extended to include a craniotomy. The procedure can be performed under general anesthesia or, if necessary, under local anesthesia. Even at an advanced age, most patients benefit greatly from the operation and recover very quickly from the procedure.
Surgical Risks
- Seizures, including refractory status epilepticus
- Intracerebral hemorrhages in approximately 0.7 - 5%12
- Pneumocephalus
- Recurrence of chronic subdural hematoma
Embolization of the Middle Meningeal Artery
In patients for whom surgical treatment with burr-hole trepanation or craniotomy is not the first-line therapy, endovascular embolization of the middle meningeal artery can be performed as treatment. The neomembranes of a chronic subdural hematoma contain neovascularization, which contributes to recurrent bleeding after surgical removal13. During embolization of the middle meningeal artery, ophthalmic collaterals should be avoided whenever possible.
Pharmacological Treatment
Because of the inflammatory pathogenesis of chronic subdural hematomas, therapies with dexamethasone have also been investigated for the treatment of chronic subdural hematomas. In a multicenter study involving 748 patients, additional treatment with dexamethasone was shown to result in worse outcomes and more frequent complications, but fewer repeat operations for recurrence14.
Outcome
Patients of advanced age often also benefit greatly from surgery, since the procedure can, under certain circumstances, be performed under local anesthesia even in high-risk patients. The mortality associated with surgical treatment of chronic subdural hematoma is approximately 0.5-8 % in the literature15 16. One-year mortality in patients with chronic subdural hematoma is approximately 32 %17.
References
Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N: Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 32:207–209, 1992 ↩ ↩
Handbook of Neurosurgery. Greenberg M, ed. 9th Edition. Thieme; 2019. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
Labadie EL, Sawaya R. In: Fibrinolysis in the Formation and Growth of Chronic Subdural Hematomas. Fibrinolysis and the Central Nervous System. Philadelphia: Hanley and Belfus; 1990:141-148. ↩ ↩
Drapkin AJ. Chronic Subdural Hematoma: Pathophysiological Basis of Treatment. Br J Neurosurg. 1991;5:467-473. ↩ ↩
Book: Neurosurgical Knowledge Update - A comprehensive review. Robert E. Harbaugh et al. Thieme Verlag. ↩ ↩ ↩ ↩ ↩ ↩
Ogasawara K, Koshu K, Yoshimoto T, et al. Transient Hyperemia Immediately After Rapid Decompression of Chronic Subdural Hematoma. Neurosurgery. 1999;45:484-489. ↩ ↩ ↩ ↩
Hutchinson, Peter J., et al. "Trial of Dexamethasone for Chronic Subdural Hematoma." New England Journal of Medicine (2020). ↩ ↩
Sambasivan M. An Overview of Chronic Subdural Hematoma: Experience with 2300 Cases. Surg Neurol. 1997;47:418-422. ↩ ↩